[236]
As compared to ofloxacin, levofloxacin has improved solubility, higher activity and lower toxicity. The overall combination of these properties of levofloxacin in a single enantiomers could not be predicted.
(Wentland Affidavit at paras. 67-68, AR, v. 31, Tab 45, pp. 9895-9896; Klibanov Affidavit at para. 133, AR, v. 12, Tab 17, p. 3446; Erhardt Cross at qq. 69-72, AR, v. 34, Tab 54, pp. 10909-10910;
Novopharm
Trial, above at para. 126.)